ASSOCIATION OF METABOLIC AND GENETIC MARKERS IN THE RISK OF DEVELOPMENT OF OSTEOPENIC CONDITIONS IN COMBINING CHRONIC PANCREATITIS AND HYPERTENSIVE DISEASE

Authors

  • L. M. Pasieshvili Kharkiv National Medical University
  • T. I. Viun Kharkiv National Medical University
  • Е. А. Lazutkina Kharkiv City Multidisciplinary Hospital No. 182

DOI:

https://doi.org/10.11603/1811-2471.2018.v0.i2.8585

Keywords:

chronic pancreatitis, hypertensive disease, vitamin D receptor gene, osteocalcin.

Abstract

In the current research, 70 patients with chronic pancreatitis (CP) and hypertensive disease (HD) were examined for the role of the vitamin D receptor gene during these diseases. It was found out that the comorbidity of nosological forms was more often observed in persons with the V-allele of polymorphism of the VDR gene (84.3 %), unlike the control (75.7 %) and the group of patients with isolated CP (77.5 %). Also, with CP and HD, osteoporotic changes were most often formed (27.3 %), in contrast to the comparison group, where there were 10 % of such patients. Significant changes are shown in osteocalcin content indicators, which depend on the polymorphism of the VDR gene.

References

Atsel, Ye.A. (2014). Effektivnost obrazovatelnykh programm v povyshenii kompetentnosti vracha v voprosakh diagnostiki i lecheniya arterialnoy gipertenzii [Efficiency of educational programs in increasing the competence of the doctor in the questions of diagnosis and treatment of arte­rial hypertension]. Spravochnik vracha obshchey praktiki – Direc­tory of the Doctor of General Practice, 3, 82-83 [in Russian].

Babinets, L.S., Kvasnitska, O.S., Mihenko, L.M., & Pin­ke­vych, O.Ya. (2011). Osteodefitsyt i vplyv suputnoi patolohii na yoho hlybynu pry khronіchnomu pankreatyti [Osteodefi­ciency and the effect of concomitant pathology on its depth in chronic pancreatitis]. Bukovynskyi medychnnyi visnyk – Bukovyna Medical Bulletin, 15, 2 (58), 183-185 [in Ukrainian].

Vertkin, A.L., Vertkin, A.L., Morgunova, L.Yu., & Nau­mova, A.V. (2007). Osteoporoz u patsiyentov s somati­cheskoy patologiyey v zavisimosti ot pola [Osteoporosis in patients with somatic pathology depending on sex]. Osteo­poroz i osteopatologiya – Osteoporosis and Osteopa­thology, 1, 25-28 [in Russian].

Yena, L.M. (2015). Vozrast kak znachimyy kompo­nent diagnostiki vtorichnykh gipertenziy [Age as a signifi­cant component of the diagnosis of secondary hyperten­sion]. Arterialnaya gipertenziya – Arterial Hypertension, 4, 42-51 [in Russian].

Kovaleva, O.N. (2014). Hlyukometabolicheskie na­ru­sheniya i serdechno sosudystyy risk [Glucometabolic disor­ders and cardiovascular risk]. Ukrainska shkola endokryno­lohii – Ukrainian School of Endocrinology, 63-73 [in Russian].

Kovalenko, V.M., & Kornatskyi, V.M. (2014). Khvo­roby systemy krovoobihu yak medyko-sotsialna i suspilno-politychna problema [Diseases of the circulatory system as a medical and social and socio-political problem]. Anali­tychno-statystychnyi posibnyk – Analytical and Statistical Manual, 279 [in Ukrainian].

Litovskiy, I.A., & Gordienko, A.V. (2013). Ateroskleroz i gipertonicheskaya bolezn. Voprosy patogeneza, diagnos­tiki i lecheniya [Atherosclerosis and hypertension. Questions of pathogenesis, diagnosis and treatment]. SpetsLit, 312 [in Russian].

Pasiyeshvili, L.M. (2016). Rol khronicheskogo pan­krea­tita v narushenii metabolizma kostnoy tkani i formiro­vanii osteoporoza [The role of chronic pancreatitis in the disturbance of bone tissue metabolism and the formation of osteoporosis]. Visnyk VDNZU “Ukrainska medychna sto­ma­tolohichna akademiia” Aktualni problemy suchasnoi me­dytsyny – Bulletin of Higher State Ebucational Establishment “Ukrainian Medical Dentistry Academy” Actual Problems of Modern Medicine, 16, 4 (56), 166-169 [in Russian].

Sirenko, Yu.N., Gorbas, I.M., & Andriyevskaya, S.A. (2014). Effektivnost i bezopasnost kombinirovannoy terapii na osnove khlortalidona i atenolola v odnoy tabletke (teno­rik) u patsiyentov s gipertonicheskoy boleznyu: pervyye re­zultaty vseukrainskogo nauchno-issledovatelskogo pro­ekta trus [Efficacy and safety of combined therapy based on chlorthalidone and atenolol in one tablet (tenorik) in pati­ents with essential hypertension: the first results of the all-Ukrainian scientific research project trus]. Arterialnaya giper­tenziya – Arterial Hypertension, 6 (38), 46-47 [in Russian].

Tkach, S.M. (2013). Prakticheskiye podkhody k diagnostike khronicheskogo pankreatita [Practical appro­aches to the diagnosis of chronic pancreatitis]. Suchasna gastroenterologia – Modern Gastroenterology, 1 (69), 136-146 [in Russian].

Bergh, J.P., Geel, T.A., & Geusens, P.P. (2012). Osteoporosis, frailty and fracture: implications for case finding and therapy. Nat. Rev. Rheumatol., 8 (3), 163-172.

Bernstein, C.N., & Leslie, W. D. (2013). The patho­physiology of bone disease in gastrointestinal disease. Eur. J. Gastroenterol. Hepatol., 15 (8), 857-864.

Dugga, S.N., Purcell, C., & Kilbane, M. (2015). An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study. Am. J. Gastroenterol., 110 (2), 336-344.

Kunes, J., Zicha, J. (2009). The interaction of gene­tic and environmental factors in the etiology of hyper­tension. Physiol. Res., 58 (2), 33-41.

Prentice, R.L., Pettinger, M.B., & Jackson, R.D. (2013). Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos. Int., 24 (2), 567-580.

Ross, A.C., Taylor, C.L., & Yaktine, A. L. (2011). Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. Dietary Reference Intakes for Calcium and Vitamin D, Washington (DC): National Academies Press (US); Retrieved from: http://www.ncbi.nlm.nih.gov/books/NBK56070.

Published

2018-08-02

How to Cite

Pasieshvili, L. M., Viun, T. I., & Lazutkina Е. А. (2018). ASSOCIATION OF METABOLIC AND GENETIC MARKERS IN THE RISK OF DEVELOPMENT OF OSTEOPENIC CONDITIONS IN COMBINING CHRONIC PANCREATITIS AND HYPERTENSIVE DISEASE. Achievements of Clinical and Experimental Medicine, (2). https://doi.org/10.11603/1811-2471.2018.v0.i2.8585

Issue

Section

Оригінальні дослідження